MedTrace Logo

Rocuronium Consumption in Etomidate-based and Propofol-based General Anesthesia Under Sevoflurane

NCT02711917 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 175

Last updated 2016-03-17

No results posted yet for this study

Summary

Different concentration of sevoflurane was given to maintain anesthesia. The dose of propofol to maintain BIS between 40-60 and the consumption of rocuronium was recorded and evaluated.

Conditions

  • Neuromuscular Monitoring

Interventions

DRUG

MAC 0.5

0.5 MAC Sevoflurane

DRUG

MAC 0.75

0.75 MAC Sevoflurane

DRUG

MAC 1.0

1.0 MAC Sevoflurane

DRUG

Propofol

Propofol consumption

DRUG

Etomidate

Etomidate consumption

DRUG

Rocuronium

Consumption of Rocuronium

Sponsors & Collaborators

  • Tianjin Medical University General Hospital

    lead OTHER

Principal Investigators

  • Guolin Wang, Professor · Head of department anesthesiology

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2015-12-31
Completion
2016-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02711917 on ClinicalTrials.gov